Navigation Links
British Doctors on Everest Mission Get Bitter Dose

A British team of doctors attempting to conduct tests on Mt Everest,// the highest peak in the world, had to swallow a bitter dose after the Nepal government said the research was illegal.

The Centre for Aviation, Space and Extreme Environment Medicine (CASE) at the University College London had announced in 2005 that it would lead an expedition to the 8,848 m peak in 2007 to measure the amount of oxygen in their own blood on the summit as well as test how well their brains, lungs and metabolisms functioned at extreme altitude.

Led by CASE director Mike Grocott, the research was intended to find out more about the changes in the human body when it is pushed to its limits during critical illness on the basis of the changes that take place in extreme environments.

The Xtreme Everest Expedition, comprising researchers working in the fields of anaesthesia, intensive care and remote medicine, planned to set up laboratories on Mt Everest as it went higher up, with the final one at South Col, at an altitude of 8,000 m.

An offshoot of the experiment, Project Everest, aimed to recruit over 1,000 volunteers to measure their heart rates and breathing at high altitudes in order to come up with fitness programmes in the future.

The team, also including cardiovascular geneticist Hugh Montgomery, physician Sundeep Dhillon, clinician Roger McMorrow, diving expert Denny Levett and space expert Kevin Fong generated worldwide media hype when it announced its plans in 2005. However, there was one thing the doctors forgot - to take the permission of the host country.

According to Nirbhay Kumar Sharma, administrative officer of the Nepal Health Research Council, the apex body overseeing all research conducted in the country:
'"/>




Page: 1

Related medicine news :

1. Designer baby for British couple
2. British Authorities Seize Spurious Drugs
3. Collaborations planned between British Organization and Indian health care industry
4. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
5. British Women Flies to India for Treatment of Breast Cancer
6. Sharp Increase In Morning-After Pill Sales Among British Women
7. British company developing ‘Safer Cigarettes
8. British man Recovered from HIV
9. British medical education suffers shortage of bodies
10. Relief For British MS Patients: Cannabis-Based Oral Spray
11. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
Post Your Comments:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 1Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 2Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 3Healthnostics Unveils Biomedical Content Strategy for Medbioworld com 14314 1Healthnostics Unveils Biomedical Content Strategy for Medbioworld com 14314 2Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 1Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 2Instrumentation Laboratory Installs 2000th ACL TOP 28R 29 System 5144 3